Organoid-based epithelial to mesenchymal transition (OEMT) model: from an intestinal fibrosis perspective
Abstract The current in vitro or in vivo intestinal fibrosis models have many limitations. Recent advancements in the isolation and culturing of organoids has led to development of various three-dimensional (3D) intestinal disease models with in vivo physiology. In this study, we generated an organo...
Guardado en:
Autores principales: | Soojung Hahn, Myeong-Ok Nam, Jung Hyun Noh, Dong Hyeon Lee, Hyun Wook Han, Duk Hwan Kim, Ki Baik Hahm, Sung Pyo Hong, Jun-Hwan Yoo, Jongman Yoo |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebee737219a842cf96b0be81c627d7ca |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Morphological screening of mesenchymal mammary tumor organoids to identify drugs that reverse epithelial-mesenchymal transition
por: Na Zhao, et al.
Publicado: (2021) -
Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions
por: Jae Eun Um, et al.
Publicado: (2017) -
Percutaneous Electromagnetic Transthoracic Nodule Localization for Ground Glass Nodules
por: Seung Hwan Song, et al.
Publicado: (2021) -
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
por: Giljae Lee, et al.
Publicado: (2020) -
Generation of mesenchyme free intestinal organoids from human induced pluripotent stem cells
por: Aditya Mithal, et al.
Publicado: (2020)